Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 941-950 of 9364

Page
per page
  1. Pamidronate Disodium
    A2456 Pamidronate Disodium
    Summary: Bisphosphonate antiresorptive agent & bone resorption inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
  2. Ivacaftor (VX-770)
    A5047 Ivacaftor (VX-770)
     1 Citation
    Summary: Potent CFTR potentiator
      insoluble in H2O; ≥19.6 mg/mL
  3. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  4. Nepafenac
    A2890 Nepafenac
    Summary: COX-1 and COX-2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥9.95 mg/mL
  5. Prasugrel
    A1607 Prasugrel
    Summary: ADP receptor inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.22 mg/mL
  6. Doripenem Hydrate
    A2036 Doripenem Hydrate
    Target: Antibiotic
    Summary: Injectable antibiotic,ultra-broad spectrum
      insoluble in EtOH; ≥10.96 mg/mL
  7. Cladribine
    A2187 Cladribine
    Target: Adenosine Deaminases
    Summary: Apoptosis inducer in CLL cells
      ≥41.67 mg/mL
  8. OSU-03012 (AR-12)
    A2846 OSU-03012 (AR-12)
     1 Citation
    Target: PDK-1
    Summary: Potent PDK1 inhibitor
      ≥23 mg/mL
  9. Dacarbazine
    A2197 Dacarbazine
    Target: DNA Alkylating
    Summary: Antineoplastic( malignant melanoma and sarcomas)
      insoluble in EtOH; ≥0.54 mg/mL
  10. Dexamethasone (DHAP)
    A2324 Dexamethasone (DHAP)
     10 Citation
    Target: interleukin receptor
    Summary: Glucocorticoidan; anti-inflammatory
      insoluble in H2O; ≥19.623 mg/mL

Items 941-950 of 9364

Page
per page